A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax

The vaccine Zostavax has been shown to prevent herpes zoster (HZ) and postherpetic neuralgia and is recommended for individuals ≥60 years of age. This study compared the safety and the immunogenicity of a refrigerator-stable formulation (Zostavax refrigerated) with those of the current formulation (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gilderman, Larry I., Lawless, James F., Nolen, Thomas M., Sterling, Tina, Rutledge, Ruth Z., Fernsler, Doreen A., Azrolan, Neal, Sutradhar, Santosh C., Wang, William W., Chan, Ivan S. F., Schlienger, Katia, Schödel, Florian, Silber, Jeffrey L.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2008
Matèries:
Vaccine Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238040/
https://ncbi.nlm.nih.gov/pubmed/18077611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00310-07
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars